Northern Trust’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $26.4M | Sell |
|
|||||
|
2024
Q1 | $28.6M | Buy |
|
|||||
|
2023
Q4 | $28.6M | Buy |
|
|||||
|
2023
Q3 | $13M | Buy |
|
|||||
|
2023
Q2 | $18.5M | Buy |
|
|||||
|
2023
Q1 | $13.5M | Buy |
|
|||||
|
2022
Q4 | $17M | Buy |
|
|||||
|
2022
Q3 | $14.4M | Buy |
|
|||||
|
2022
Q2 | $13.3M | Buy |
|
|||||
|
2022
Q1 | $14.4M | Sell |
|
|||||
|
2021
Q4 | $13.8M | Buy |
|
|||||
|
2021
Q3 | $12.2M | Buy |
|
|||||
|
2021
Q2 | $9.73M | Buy |
|
|||||
|
2021
Q1 | $956K | Buy |
|
|||||
|
2020
Q4 | $1.09M | Buy |
|